Literature DB >> 23698276

Imatinib results in better outcomes than HLA-identical sibling transplants in young persons with newly diagnosed chronic-phase chronic myelogenous leukemia.

Q Jiang1, L-P Xu, D-H Liu, K-Y Liu, R P Gale, M-J Zhang, B Jiang, X-H Zhang, Y Wang, S-S Chen, X-Y Zhao, H Chen, H Jiang, Y-H Chen, W Han, Y-Z Qin, Y-R Liu, Y-Y Lai, M Lv, X-J Huang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23698276     DOI： 10.1038/leu.2013.159

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

1.  Health-related quality of life of patients with newly diagnosed chronic myeloid leukemia treated with allogeneic hematopoietic SCT versus imatinib.

Authors:  X-D Mo; Q Jiang; L-P Xu; D-H Liu; K-Y Liu; B Jiang; H Jiang; H Chen; Y-H Chen; X-H Zhang; W Han; Y Wang; X-J Huang
Journal:  Bone Marrow Transplant       Date:  2014-01-20       Impact factor: 5.483

Review 2.  The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology.

Authors:  Lanping Xu; Hu Chen; Jing Chen; Mingzhe Han; He Huang; Yongrong Lai; Daihong Liu; Qifa Liu; Ting Liu; Ming Jiang; Hanyun Ren; Yongping Song; Zimin Sun; Jianmin Wang; Depei Wu; Daobin Zhou; Ping Zou; Kaiyan Liu; Xiaojun Huang
Journal:  J Hematol Oncol       Date:  2018-03-02       Impact factor: 17.388

3.  Impact of socio-demographic co-variates on prognosis, tyrosine kinase-inhibitor use and outcomes in persons with newly-diagnosed chronic myeloid leukaemia.

Authors:  Lu Yu; Huifang Wang; Robert Peter Gale; Yazhen Qin; Yueyun Lai; Hongxia Shi; Xuelin Dou; Xiaojun Huang; Qian Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-09       Impact factor: 4.553
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.